Marshall Urist Insider Trades & Stock Holdings

EVP, Research & Investments · Royalty Pharma plc · Latest filing Jun 24, 2026

Marshall Urist, EVP, Research & Investments at Royalty Pharma plc has 1 Form 4 trade on file since Jun 24, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($502.03K), net -$502.03K. Latest filing: disposed of 9.10K shares of $RPRX on Jun 24, 2026 at $55.18.

Trades on file

1

Open-market bought

$0

Open-market sold

$502.03K

Net open-market

-$502.03K

Latest filing

Jun 24, 2026

All insider trades by Marshall Urist

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 24, 2026	$RPRX	Sell (Open-market sale) 10b5-1	9.10K	$55.18	$502.03K			+2.8%	+8.4%		EVP, Research & Investments		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Marshall Urist traded

• $RPRX

Frequently asked questions

Has Marshall Urist been buying or selling stock?

Marshall Urist has 0 open-market purchases and 1 open-market sale on file, net -$502.03K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Marshall Urist's latest insider trade?

disposed of 9.10K shares of $RPRX on Jun 24, 2026 at $55.18.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.